Marshall Wace, LLP Edwards Lifesciences Corp Transaction History

Marshall Wace, LLP

$78.4 Billion
Q4 2024

A detailed history of Marshall Wace, LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 5,813,419 shares of EW stock, worth $412 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

5,813,419

Previous 3,733,777 55.7%

Holding current value

$412 Million

Previous $246 Million 74.67%

% of portfolio

0.55%

Previous 0.32%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$64.54 - $75.92 $134 Million - $158 Million	2,079,642 Added 55.7%	5,813,419 $430 Million
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $218 Million - $343 Million	3,659,111 Added 4900.64%	3,733,777 $246 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $8.79 Million - $9.84 Million	-104,328 Reduced 58.29%	74,666 $6.9 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $5.51 Million - $7.26 Million	75,973 Added 73.75%	178,994 $17.1 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $104 Million - $131 Million	-1,682,776 Reduced 94.23%	103,021 $7.86 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $192 Million - $259 Million	-2,777,940 Reduced 60.87%	1,785,797 $124 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $32.7 Million - $37.9 Million	-402,059 Reduced 8.1%	4,563,737 $430 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $60.3 Million - $68.6 Million	811,769 Added 19.54%	4,965,796 $411 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $43.8 Million - $56.1 Million	641,715 Added 18.27%	4,154,027 $310 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $181 Million - $236 Million	2,199,410 Added 167.52%	3,512,312 $290 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $76.4 Million - $113 Million	883,380 Added 205.67%	1,312,902 $125 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $25.4 Million - $31.9 Million	248,806 Added 137.68%	429,522 $50.6 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $18.2 Million - $22.3 Million	171,005 Added 1760.94%	180,716 $23.4 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $1.84 Million - $2.2 Million	-17,904 Reduced 64.83%	9,711 $1.1 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $5.69 Million - $7.11 Million	-67,905 Reduced 71.09%	27,615 $2.86 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $7.52 Million - $8.66 Million	95,520 New	95,520 $7.99 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $2.73 Million - $3.48 Million	-38,145 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $95,073 - $123,727	-1,415 Reduced 3.58%	38,145 $3.04 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $1.48 Million - $1.98 Million	25,714 Added 185.71%	39,560 $2.73 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $2.95 Million - $4.55 Million	-56,219 Reduced 80.24%	13,846 $2.61 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $4.08 Million - $4.68 Million	56,971 Added 435.09%	70,065 $16.3 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $3.95 Million - $4.84 Million	-64,225 Reduced 83.06%	13,094 $2.88 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $2.09 Million - $2.41 Million	37,433 Added 93.85%	77,319 $14.3 Million
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $1.91 Million - $2.55 Million	39,886 New	39,886 $7.63 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $630,065 - $800,059	-13,787 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $585,258 - $707,273	13,787 New	13,787 $2.01 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $413,069 - $527,027	-11,107 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $46,528 - $54,240	1,377 Added 14.15%	11,107 $1.25 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $353,101 - $377,815	9,730	9,730 $1.06 Million

Others Institutions Holding EW

# of Institutions

1,383

Shares Held

487M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Edwards Lifesciences Corp Transaction History